Delivery Order SPE2DB22D3009-SPE2DB23FAQ86
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,235.55 delivery order is for the supply of 4 mg Ondansetron ODT tablets, which are used to treat nausea and vomiting. The contract has an ultimate completion date of April 18, 2023 and is a firm fixed-price delivery order under the DLA's Indefinite Delivery Contract (IDC) with Cencora, Inc. valued at up to $999,999,999.00. This IDC serves as the...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $8,321.36, is for the delivery of Ondansetron ODT 8 mg tablets to support medical supply needs. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,153.42 firm fixed-price delivery order is for the supply of 4562730527 - Ondansetron ODT 8 mg Tablets, 30s. The contract has an ultimate completion date of November 7, 2023 and was awarded on November 6, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $10,582.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets in 30-count packages, which are used to treat nausea and vomiting. The award is a delivery order under an Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running through December...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,816.93 delivery order is for the supply of Ondansetron ODT 4 mg tablets, with a completion date of September 21, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to efficiently...
- This federal contract award, valued at $7,006.29, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. This contract is a delivery order that is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc., valued at up to $999,999,999.00 and running through December 2025. The...
- This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,092.97 firm fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,179.76, is a Firm Fixed Price Delivery Order for the supply of Ondansetron ODT 8 mg Tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver 4,561,783,106 units of Ondansetron ODT 4 mg tablets. The $4,427.20 firm-fixed-price delivery order has an ultimate completion date of August 14, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides the Defense Logistics Agency (DLA) with Ondansetron ODT 4 mg Tablet UD 30s, a medication used to prevent nausea and vomiting. The $3,223.20 firm fixed-price delivery order has an ultimate completion date of August 31, 2021. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB23FAQ86Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,833.77 firm fixed-price delivery order covers the supply of Ondansetron ODT 8 MG Tablets, a pharmaceutical product used to treat nausea and vomiting. The contract has an ultimate completion date of May 16, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 5/15/23 |